* Featuring perspectives from Dr Andrew J Armstrong and Dr Maha Hussain, including the following topics:  __ __ * CME information and select publications   

1h 1m

Mar 28

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer | Faculty Presentation 2: Other Available and Emerging Therapeutic Approaches in Prostate Cancer —  Andrew J Armstrong, MD, ScM CME information and select publications

50m

Mar 28

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer | Faculty Presentation 1: Optimizing the Role of Hormonal Therapy and Novel Therapeutic Strategies for Patients with Prostate Cancer — Maha Hussain, MD, FACP, FASCO CME information and select publications

55m

Mar 28

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma | Faculty Presentation 2: Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma — Andrew M Evens, DO, MBA, MSc   CME information and select publications 

1h 0m

Mar 27

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma | Faculty Presentation 1: Follicular and Mantle Cell Lymphoma — Sonali M Smith, MD CME information and select publications 

45m

Mar 27

* Featuring perspectives from Dr Andrew M Evens and Dr Sonali M Smith, including the following topics:  __ __ * CME information and select publications   

1h 0m

Mar 27

* Featuring perspectives from Dr Seth Wander, including the following topics: __ __ * CME information and select publications  

1h 19m

Mar 26

* Featuring perspectives from Dr Robin (Katie) Kelley and Dr Mark Yarchoan, including the following topics:  __ __ * CME information and select publications   

1h 1m

Mar 21

* Featuring perspectives from Dr Melissa Johnson, including the following topics: __ __ * CME information and select publications  

1h 2m

Mar 20

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer | Faculty Presentation 2: Triple-Negative Breast Cancer — Priyanka Sharma, MD CME information and select publications

44m

Mar 15

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer | Faculty Presentation 1: HER2-Positive Breast Cancer — Ian E Krop, MD, PhD CME information and select publications

53m

Mar 15

* Featuring perspectives from Dr Ian E Krop and Dr Priyanka Sharma, including the following topics:  __ __ * CME information and select publications   

1h 5m

Mar 15

Featuring perspectives from Dr Petros Grivas, Dr Vadim S Koshkin, Dr Kriti Mittal, Dr Mamta Parikh and Dr Scott T Tagawa, including the following topics: First-Line Treatment of Metastatic Urothelial Bladder Cancer (mUBC) — Enfortumab Vedotin/Pembrolizumab __ __ Other Approaches to First-Line Treatment of mUBC — Nivolumab/Chemotherapy __ __ Integrating Enfortumab Vedotin Monotherapy into the Treatment of mUBC __ __ * * Integrating Sacituzumab Govitecan into the Treatment of mUBC __ __ * FGFR-Targeted Therapy for mUBC — Erdafitinib   * __ __ * HER2-Targeted Therapy for mUBC — Trastuzumab Deruxtecan, Disitamab Vedotin __ __ * CME information and select publications 

2h 7m

Mar 13

Featuring a slide presentation and related discussion from Dr Komal Jhaveri, including the following topics: __ __ CME information and select publications

40m

Mar 11

Featuring an interview with Dr Komal Jhaveri, including the following topics: __ __ CME information and select publications

38m

Mar 11

Featuring perspectives from Dr Stephen T Oh, including the following topics: __ __ CME information and select publications

1h 0m

Mar 08

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers | Faculty Presentation 1: Immunotherapy in Gastroesophageal Cancers — Yelena Y Janjigian, MD CME information and select publications

28m

Mar 07

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers | Faculty Presentation 2: Other Treatment Approaches for Gastroesophageal Cancers — Zev Wainberg, MD, MSc CME information and select publications

36m

Mar 07

Featuring perspectives from Dr Yelena Y Janjigian and Dr Zev Wainberg, including the following topics: __ __ CME information and select publications

1h 2m

Mar 07

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Chronic Lymphocytic Leukemia | Faculty Presentation 1: Current Management Approaches for Patients with Chronic Lymphocytic Leukemia (CLL) — Jeff Sharman, MD   CME information and select publications  

53m

Feb 27

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Chronic Lymphocytic Leukemia | Faculty Presentation 2: Future Directions in the Care of Patients with CLL — Lindsey Roeker, MD CME information and select publications

52m

Feb 27

Featuring perspectives from Dr Lindsey Roeker and Dr Jeff Sharman, including the following topics: __ __ CME information and select publications  

58m

Feb 27

Featuring perspectives from Dr Ahmed Omar Kaseb and Prof Arndt Vogel, including the following topics: __ __ CME information and select publications

1h 0m

Feb 23

Featuring perspectives from Dr Rahul Aggarwal, Dr Emmanuel S Antonarakis, Dr Elisabeth I Heath and Dr A Oliver Sartor, moderated by Dr Alan H Bryce, including the following topics: __ __ CME information and select publications  

1h 52m

Feb 20

Featuring perspectives from Dr Bradley J Monk, including the following topics: __ __ CME information and select publications

59m

Feb 16

Featuring perspectives from Dr Tanios Bekaii-Saab, Dr Andrea Cercek, Dr Cathy Eng and Dr John Strickler, moderated by Dr Christopher Lieu, including the following topics: __ __ CME information and select publications

2h 0m

Feb 15

Featuring perspectives from Dr Matthew Milowsky, Dr Peter H O’Donnell, Dr Jonathan E Rosenberg and Dr Arlene Siefker-Radtke, moderated by Dr Evan Y Yu, including the following topics: __ __ CME information and select publications    

1h 59m

Feb 09

Featuring perspectives from Dr David H Ilson, Dr Rutika Mehta, Dr Markus Moehler and Dr Manish A Shah, moderated by Dr Harry H Yoon, including the following topics: __ __ CME information and select publications

2h 0m

Feb 07

Featuring perspectives from Dr Stephanie L Graff and Dr Erica Mayer, including the following topics: __ __ CME information and select publications

1h 4m

Feb 01

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer | Faculty Presentation 2: Relevant Advances in the Care of Patients with HR-Positive Metastatic BC (mBC) — Erica Mayer, MD, MPH, FASCO CME information and select publications

48m

Feb 01